Management of postcardiac arrest myocardial dysfunction
Wulfran Bougouin1, Alain Cariou
1Medical Intensive Care Unit, AP-HP, Cochin University Hospital, Paris Cedex 14, France.
Current Opinion in Critical Care
|March 21, 2013
Summary
Postresuscitation myocardial dysfunction (PRMD) is a common, reversible complication after resuscitation. Aggressive management, including ischemia detection and inotropic support, improves outcomes, with neurological status being the key determinant.
Area of Science:
- Cardiology
- Critical Care Medicine
Background:
- Postresuscitation myocardial dysfunction (PRMD) is a frequent and potentially lethal complication following cardiac arrest.
- It significantly worsens hemodynamic status, making early identification crucial for patient management.
Purpose of the Study:
- To review the characteristics, diagnosis, and management of postresuscitation myocardial dysfunction.
- To emphasize the importance of early identification and treatment strategies for PRMD.
Main Methods:
- Echocardiography is the primary diagnostic tool for characterizing PRMD.
- Assessment includes evaluation of systolic and diastolic myocardial function.
Main Results:
- PRMD typically manifests within minutes of resuscitation and is reversible within 48-72 hours.
- Dobutamine is the standard treatment for systolic dysfunction; mechanical circulatory assistance may be needed in severe cases.
- Myocardial ischemia should be investigated if a coronary cause is suspected.
Conclusions:
- The reversibility of PRMD supports an aggressive management approach.
- Key interventions include ischemia detection, inotropic support, and mechanical circulatory assistance when necessary.
- Neurological outcome, rather than hemodynamic status, is the primary determinant of patient prognosis.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiopulmonary Resuscitation IV: Pharmacological Management
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...


